Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Mid-range Performer

1935.4000 8.60 (0.45%)

NSE Sep 02, 2025 12:03 PM

51.74% Gain from 52W Low

Volume: 100.3K

Glenmark Pharmaceuticals Ltd.

23 May 2025

1935.40

0.45%

Investor Presentation

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation Q4, F.Y. 2024-25

More from Glenmark Pharmace…

All earning calls

Investor presentations from Glenmark Pharmace…

All investor presentations